PDCD1 and cancer: The microneedle patch overcame the resistance exhibited by the tumour cells to free anti-PD1 due to the synergistic effect of the combination of cisplatin and anti-PD1 coated with lipids indicating a new direction in treatment of resistant forms of cancer [86].